Stratec SESRBZF 64 Shareholder Yield % is 2.58% as of Mar. 2026, which is 93% above its 10-year median of 1.34. GuruFocus rates SRBZF with a GF Score™ of 64/100 and a GF Value™ of $129.40. The stock has 5 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Stratec SE ranks better than 72% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Stratec SE's Shareholder Yield % was 2.58%.
Stratec SE (OTCPK:SRBZF) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Stratec SE Shareholder Yield % Related Terms
Stratec SE Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Stratec SE's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRBZF vs ABT, SYK, MDT: Shareholder Yield % Comparison
For the Medical Devices subindustry, Stratec SE's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stratec SE Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Stratec SE's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Stratec SE (SRBZF) has a Shareholder Yield % of 2.58% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Stratec SE and its competitors. This is 93% above median its historical median of 1.34. According to the industry distribution chart, Stratec SE ranks #229 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 28%.
Is Stratec SE's Shareholder Yield % too high?
Stratec SE's current Shareholder Yield % of 2.58% is 93% above median its 10-year median of 1.34. The Medical Devices & Instruments industry median Shareholder Yield % is 0.17. Stratec SE's value of 2.58% is 1463.6% above this industry median. Based on the distribution chart, Stratec SE ranks #229 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stratec SE has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Stratec SE's Shareholder Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Stratec SE ranks #229 out of 818 companies for Shareholder Yield %. This puts Stratec SE in the upper half of its industry. The industry median Shareholder Yield % is 0.17. Stratec SE's value of 2.58% is 1463.6% above this benchmark. While the company's 10-year median is 1.34 vs. the industry median of 0.17, Stratec SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.17, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stratec SE's current Shareholder Yield % of 2.58% is 1463.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Stratec SE and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stratec SE's current Shareholder Yield % is 2.58%, which is 93% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stratec SE stock overvalued right now?
Stratec SE (SRBZF) has a current Shareholder Yield % of 2.58%. The stock's GF Value™ is $129.40, compared to a current price of $72.96 — trading 43.6% below its estimated fair value. The current Shareholder Yield % is 2.58%, which is 93% above median its 10-year median of 1.34 and 1463.6% above the Medical Devices & Instruments industry median of 0.17. Stratec SE's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Stratec SE (SRBZF), the current Shareholder Yield % is 2.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stratec SE (SRBZF) Overvalued in 2026?
Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued.
The current stock price of $72.96 is trading 43.6% below its estimated GF Value™ of $129.40.
Key valuation signals for SRBZF:
Shareholder Yield %: 2.58% (93% above median its 10-year median of 1.34)
GF Value™: $129.40 vs. price of $72.96 (43.6% below fair value)
Industry Position: 1463.6% above the Medical Devices & Instruments median (#229 of 818)
No single metric tells the full story. See the SRBZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
64GF Score
Get the complete analysis for SRBZF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRBZF has been successfully added to your 
